Gabelli Funds LLC Raises Position in Chemed Corporation $CHE

Key Points

• Gabelli Funds LLC increased its stake in Chemed (NYSE:CHE) by 8.5% in Q3, buying 2,634 shares to hold 33,601 shares valued at about $15.05 million (≈0.24% of the company).
• Chemed missed Q expectations—EPS $6.42 vs. $7.02 est. and revenue $639.34M vs. $659.09M—issued FY2026 EPS guidance of $23.25–$24.25, and has drawn analyst downgrades leaving a consensus "Hold" with an average target of $498.

Gabelli Funds LLC grew its stake in Chemed Corporation (NYSE:CHE - Free Report) by 8.5% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 33,601 shares of the company's stock after purchasing an additional 2,634 shares during the period. Gabelli Funds LLC owned approximately 0.24% of Chemed worth $15,045,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Gamco Investors INC. ET AL increased its position in shares of Chemed by 0.8% during the 3rd quarter. Gamco Investors INC. ET AL now owns 20,448 shares of the company's stock valued at $9,155,000 after purchasing an additional 168 shares during the last quarter. Aptus Capital Advisors LLC lifted its position in Chemed by 12.7% in the third quarter. Aptus Capital Advisors LLC now owns 56,624 shares of the company's stock worth $25,353,000 after buying an additional 6,368 shares during the last quarter. Barclays PLC boosted its stake in Chemed by 39.6% during the third quarter. Barclays PLC now owns 22,874 shares of the company's stock worth $10,242,000 after buying an additional 6,485 shares during the period. Dimensional Fund Advisors LP boosted its stake in Chemed by 5.6% during the third quarter. Dimensional Fund Advisors LP now owns 240,180 shares of the company's stock worth $107,542,000 after buying an additional 12,810 shares during the period. Finally, Cresset Asset Management LLC bought a new position in Chemed during the third quarter valued at $204,000. Hedge funds and other institutional investors own 95.85% of the company's stock.

Chemed Trading Down 1.0%

NYSE:CHE opened at $408.06 on Friday. The company has a market cap of $5.62 billion, a price-to-earnings ratio of 22.21, a price-to-earnings-growth ratio of 1.62 and a beta of 0.46. Chemed Corporation has a twelve month low of $385.00 and a twelve month high of $623.60. The stock has a fifty day simple moving average of $444.21 and a 200-day simple moving average of $442.77.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The company reported $6.42 EPS for the quarter, missing analysts' consensus estimates of $7.02 by ($0.60). The company had revenue of $639.34 million during the quarter, compared to the consensus estimate of $659.09 million. Chemed had a return on equity of 25.66% and a net margin of 10.48%.The company's revenue for the quarter was down .1% on a year-over-year basis. During the same quarter in the previous year, the company posted $6.83 earnings per share. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. As a group, equities research analysts predict that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Shareholders of record on Monday, February 23rd will be paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Monday, February 23rd. Chemed's dividend payout ratio is currently 13.06%.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the stock. Zacks Research downgraded shares of Chemed from a "hold" rating to a "strong sell" rating in a research note on Wednesday. Royal Bank Of Canada reiterated a "sector perform" rating and set a $422.00 price target (down from $572.00) on shares of Chemed in a report on Friday, February 27th. Jefferies Financial Group lowered shares of Chemed from a "buy" rating to a "hold" rating in a research report on Thursday, January 22nd. Weiss Ratings reissued a "hold (c-)" rating on shares of Chemed in a research note on Wednesday, January 21st. Finally, Oppenheimer dropped their target price on Chemed from $580.00 to $500.00 and set an "outperform" rating for the company in a research report on Friday, February 27th. Two analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $498.00.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.